EcoNugenics, Santa Rosa, CA, claims a recent meta-analysis of 19 published clinical trials on Padma Basic, a Tibetan herbal formula, shows that the preparation is safe and effective in providing significant relief for a common vascular condition—peripheral arterial disease (PAD). The meta-analysis was conducted on 2084 patients with PAD. The scientist reviewers at the Department of Internal Medicine, Complementary Medicine, at the University Hospital in Zurich, concluded: “A total of 19 trials have reported on 2084 patients to date, 444 of which were in six controlled clinical studies on PAD. The safety profile appears to be favorable. Available evidence also shows that Padma Basic (European trade name Padma 28) provides significant relief from (PAD-related) symptoms of a similar order of magnitude as other employed medications.” This recent meta-analysis of clinical trials with Padma Basic (Melzer 2006) indicates that this Tibetan herbal formula supports healthy circulation without side effects and with the similar results found with standard medications.